View Full Paper

Digital Identity and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons

• IoT
• Epidemiology
• AIOps

Abstract

This essay investigates “Digital Identity and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons” using a randomized controlled trial design. Through a behavioral lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.